Genentech

An obscure Obamacare provision forces rural hospitals to pay full price for drugs that many bigger hospitals buy at deeply discounted rates.
The death of a pioneer in black arts lobbying has Washington operatives pointing fingers and lawyering up.
A growing number of companies - from hi-tech corporations like Yahoo and Intel, to healthcare corporations like Kaiser Permanente and Genentech - are taking a more holistic and sophisticated view of health.
Horrific outcomes predicted by generational accountants and economic doomsayers will not come true as foreseen, partly because the generations over age fifty shift paradigms, create new industries, abolish others, and ultimately reshape the social and economic landscape.
One of the reasons Silicon Valley has become such a popular locus for the technology revolution is that it is darn beautiful here. The weather is salubrious, perhaps too hot in the most intense part of summer, but mostly temperate.
Despite reports of corporate and other highrollers offended at alleged aloofness and a lack of perks from the White House during the first term, this time, they'll be welcomed with open arms. The president said it himself -- he likes a good party.
A new drug called T-DM1 appears to be relatively effective and safe for women with metastatic, Her2+ breast cancer, in itself and as compared to the standard XL regimen.
New research at Genentech Inc. is challenging conventional thinking about Alzheimer's disease, providing a provocative theory
Maybe a reality check isn't something you want when you're being bombarded with "Breast Cancer Awareness" messages. After all, that would be kind of scary.
PARIS -- The Swiss drug maker Roche Holding said Monday that it was offering about $43.7 billion to acquire the 44 percent
We'll say this for the U.S. economy: It can take a punch. Consider the blows it has absorbed just this year. The worst real